Oryzon Genomics (ORYZF) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 7 18 sessions, September 22, 2025 to September 9, 2026
- Largest daily move
- -22.7% close of September 26, 2025
- 5-year change
- -19.9% closing prices, September 9, 2021 to September 9, 2026
Company Description
Oryzon Genomics (OTC Link: ORYZF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $256.6M.
ORYZF has declined 1.5% so far this year. The last closing price was $3.31.
This page collects what Stock Titan holds for ORYZF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Oryzon Genomics (ORYZF) closed at $3.31 on September 9, 2026. So far this year, the price has lost 1.5%.
ORYZF Metrics & Rankings
Price returns through September 9, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Oryzon Genomics has 10 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include fda approval, clinical trial. View all ORYZF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Oryzon Genomics (ORYZF) currently stands at 4.9 thousand shares, up 4797.0% from the previous reporting period, representing 0.0% of the float. Since September 2025, short interest has increased by 23219.0%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Oryzon Genomics (ORYZF) currently stands at 1.1 days, up 14% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 99.9% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
ORYZF Company Profile & Sector Positioning
Oryzon Genomics (ORYZF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing ORYZF often look at related companies in the same sector, including Hansa Medical AB (HNSBF), Silence Therapeutics Plc (SLNCF), Bioinvent Intern (BOVNF), Nervgen Pharma Corp (NGENF), and Adocia (ADOCY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ORYZF's relative position within its industry.